AI-generated summary
This scoping review synthesized preclinical and clinical studies on photobiomodulation for multiple sclerosis to map its proposed mechanisms, such as mitochondrial, antioxidant and anti-inflammatory effects. The authors report that photobiomodulation was associated with these mechanistic changes and describe the evidence as supporting therapeutic potential. The abstract does not give study counts or wavelengths, and it does not state how strong or consistent the evidence is.
- Who or what was studied
- Multiple sclerosis; animal and human clinical models
- Limits stated in the abstract
- The abstract does not report included study numbers, wavelengths, dosing or certainty of evidence, and the mechanisms are described as incompletely elucidated.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.